Trinity Legacy Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,685
Closed -$271K 111
2026
Q1
$271K Sell
2,685
-16,231
-86% -$1.83M 0.06% 96
2025
Q4
$2.37M Buy
18,916
+681
+4% +$86.8K 0.54% 62
2025
Q3
$2.25M Buy
18,235
+934
+5% +$123K 0.52% 63
2025
Q2
$2.28M Buy
17,301
+15,731
+1,002% +$2.07M 0.55% 62
2025
Q1
$203K Buy
+1,570
New +$200K 0.05% 93
2022
Q3
Sell
-3,353
Closed -$365K 73
2022
Q2
$365K Buy
3,353
+25
+0.8% +$2.84K 0.14% 72
2022
Q1
$394K Sell
3,328
-45
-1% -$5.58K 0.13% 72
2021
Q4
$475K Buy
3,373
+1,019
+43% +$130K 0.16% 70
2021
Q3
$278K Buy
2,354
+468
+25% +$57.5K 0.1% 88
2021
Q2
$224K Hold
1,886
0.08% 92
2021
Q1
$235K Buy
+1,886
New +$223K 0.09% 80

Other funds holding ABT

Trinity Legacy Partners's ABT Position: Q2 2026 in Review

Trinity Legacy Partners sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,685 shares — an estimated $271K sold.

Trinity Legacy Partners first reported a position in ABT in Q1 2021 and held it in 11 quarters. The position peaked at $2.37M in Q4 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Trinity Legacy Partners reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Trinity Legacy Partners sold 2,685 Abbott shares in Q2 2026, an estimated $271K.
  • Trinity Legacy Partners first reported a position in Abbott in Q1 2021 and held it in 11 quarters.
  • Trinity Legacy Partners's Abbott position peaked at $2.37M in Q4 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.